ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

ALDURAZYME
Inborn errors of metabolism
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

ALDURAZYME Rx

Generic Name and Formulations:
Laronidase 0.58mg/mL; soln for IV infusion after dilution; preservative-free.

Company:
Sanofi Genzyme Company

Therapeutic Use:

Indications for ALDURAZYME:

For the treatment of Hurler and Hurler-Scheie forms of Mucopolysaccharidosis I (MPS I) and for patients with the Scheie form who have moderate to severe symptoms.

Adults and Children:

<6 months: not recommended. ≥6 months: Pretreat with antipyretics and/or antihistamines 60mins prior to starting infusion. Give by IV infusion over 3–4hrs. Initial infusion rate: 10mcg/kg/hr, may be increased every 15min during the 1st hour, as tolerated, until max rate of 200mcg/kg/hr which is maintained for the remainder of infusion (2–3hrs). 0.58mg/kg once weekly.

Warnings/Precautions:

Discontinue immediately if severe anaphylactic or allergic reactions develop; have appropriate medical support measures available. Compromised respiratory function or acute respiratory disease: increased risk of infusion-related reactions. Labor & delivery. Pregnancy (Cat.B). Nursing mothers.

Pharmacological Class:

Recombinant human alpha-L-iduronidase enzyme.

Adverse Reactions:

Rash, upper respiratory tract infection, inj site reaction, hyperreflexia, paresthesia, flushing, poor venous access, pyrexia, chills, increased BP, tachycardia, decreased oxygen saturation.

Note:

Visit www.MPSIregistry.com or call (800) 745-4447 to enroll pregnant women with MPS I.

How Supplied:

Single-use vial (5mL)—1

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs